APPLICATIONS

Strategic Product Pipeline

From Molecular Discovery to Clinical Translation

Hermez Nanomedicine leverages a modular LNP platform to transform high-potential candidates into clinically viable therapeutic programs. By integrating nanoengineering and pharmacokinetic modeling, we de-risk delivery-dependent programs and accelerate advancement.

Oncology Program

Metabolic Diseases Program

Oncology Program

Metabolic Diseases Program

Oncology Metabolic Diseases

Precision Engineering
Leveraging 30–50 nm structures to enhance tissue permeability and maximize the EPR effect in tumor tissues.
Therapeutic Goal
Expanding the therapeutic index by reducing systemic toxicity and dose-limiting side effects.
Supported Modalities
siRNA, mRNA, and small molecule chemotherapy.

Selective Targeting
Programmable lipid compositions and surface modifications for tissue-selective delivery to organs like the liver or spleen.
Therapeutic Goal
Achieving controlled release kinetics for systemic metabolic regulation.
Supported Modalities
Peptide-based therapeutics and nucleic acid constructs.